Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference

Race Oncology (ASX:RAC) CEO Phil Lynch provides an update on the Company’s activities and new strategy as part of their participation in the ASX Small and Mid-Cap Conference 2022.